President and Chief Executive Officer

Fred Guerard, Pharm.D. joins Qlaris as President and Chief Executive Officer. Dr. Guerard brings more than two decades of global leadership experience in ophthalmology and biotechnology, with a track record of advancing innovative therapies through late-stage development and toward commercialization.

Dr. Guerard most recently served as CEO of Opthea, where he strengthened the company’s strategic and financial position as it advanced its pivotal program. Previously, he was president and CEO of Graybug Vision, leading the company through a Series C financing and its initial public offering. Prior to Graybug, he served as worldwide franchise head of ophthalmology at Novartis, overseeing a global portfolio across the Novartis retina and Alcon pharmaceuticals businesses and executing multiple strategic transactions to expand the pipeline. During his two decades at Novartis, he held several senior leadership roles across Europe, Asia-Pacific, and emerging markets.

He holds a Doctor of Pharmacy degree and a Master of Biological and Medical Sciences from the University of Rouen, France, and a Master of Marketing from HEC Paris. He currently serves as a non-executive director on the boards of Lenz Therapeutics, CalciMedica, Spiral Therapeutics and Unither Pharmaceuticals.